Structural and functional relationships of the steroid hormone receptors' N-terminal transactivation domain

Steroids

Volumn 74, Issue 12, 2009, Pages 877-883

  Kumar, Raj ^a   Litwack, Gerald ^a  

^a Janet Weis Children s Hospital   (United States)

Author keywords

Activation function; Intrinsically disordered protein; Protein folding; Protein:protein interactions; Steroid hormone receptors

Indexed keywords

STEROID RECEPTOR;

AMINO TERMINAL SEQUENCE; GENE CONTROL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN DOMAIN AF1; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; HORMONES; HUMANS; PROMOTER REGIONS, GENETIC; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, STEROID; TRANSCRIPTIONAL ACTIVATION;

EID: 69949131670     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2009.07.012     Document Type: Review

References (89)

1. Beato M., and Klug J. Steroid hormone receptors: an update. Hum Reprod Update 6 (2000) 225-236
2. Chawla A., Repa J.J., Evans R.M., and Mangelsdorf D.J. Nuclear receptors and lipid physiology: opening the X-files. Science 294 (2001) 1866-1870
3. Li X., and O'Malley B.W. Unfolding the action of progesterone receptors. J Biol Chem 278 (2003) 39261-39264
4. Lonard D.M., and O'Malley B.W. Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation. Mol Cell 27 (2007) 691-700
5. Kumar R., and Thompson E.B. The structure of the nuclear hormone receptors. Steroids 64 (1999) 310-319
6. Hollenberg S.M., Weinberger C., Ong E.S., Cerelli G., Oro A., Lebo R., et al. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318 (1985) 635-641
7. Green S., Walter P., Kumar V., Krust A., Bornert J.M., Argos P., et al. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320 (1986) 134-139
8. Escriva H., Bertrand S., and Laudet V. The evolution of the nuclear receptor superfamily. Essays Biochem 40 (2004) 11-26
9. Thornton J.W. Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansions. Proc Natl Acad Sci U S A 98 (2001) 5671-5676
10. Thornton J.W., Need E., and Crews D. Resurrecting the ancestral steroid receptor: ancient origin of estrogen signaling. Science 301 (2003) 1714-1717
11. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science 240 (2003) 889-895
12. Beato M. Gene regulation by steroid hormones. Cell 56 (1989) 335-344
13. Yamamoto K.R. Steroid receptor regulated transcription of specific genes and gene network. Annu Rev Genet 19 (1985) 209-252
14. Simons Jr. S.S. Function/activity of specific amino acids in glucocorticoid receptors. Vitamins and hormones (1999), Academic Press, Inc. p. 49-130
15. Danielian P.S., White R., Lees J.A., and Parker M.G. The structural basis of estrogen receptor/coactivator recognition and the antagonism of the interaction by tamoxifen. EMBO J 11 (1992) 1025-1033
16. Simental J.A., Sar M., Lane M.V., French F.S., and Wilson E.M. Transcriptional activation and nuclear targeting signals of the human androgen receptor. J Biol Chem 266 (1991) 510-518
17. Danielian P.S., White R., Lees J.A., and Parker M.G. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J 11 (1992) 1025-1033
18. Ikonen T., Palvimo J.J., and Janne O.A. Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators. J Biol Chem 272 (1997) 29821-29828
19. Metivier R., Penot G., Flouriot G., and Pakdel F. Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains. Mol Endocrinol 15 (2001) 1953-1970
20. Montano M.M., Ekena K., Krueger K.D., Keller A.L., and Katzenellenbogen B.S. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens. Mol Endocrinol 10 (1996) 230-242
21. Kraus W.L., McInerney E.M., and Katzenellenbogen B.S. Ligand-dependent, transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor. Proc Natl Acad Sci U S A 92 (1995) 12314-12318
22. Tetel M.J., Giangrande P.H., Leonhardt S.A., McDonnell D.P., and Edwards D.P. Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo. Mol Endocrinol 13 (1999) 910-924
23. Kumar R., and Thompson E.B. Transactivation functions of the N-terminal domains of nuclear hormone receptors: protein folding and coactivator interactions. Mol Endocrinol 17 (2003) 1-10
24. Alen P., Claessens F., Verhoeven G., Rombauts W., and Peeters B. The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription. Mol Cell Biol 19 (1999) 6085-6097
25. He B., Lee L.W., Minges J.T., and Wilson E.M. Dependence of selective gene activation on the androgen receptor NH2- and COOH-terminal interaction. J Biol Chem 277 (2002) 25631-25639
26. Bommer M., Benecke A., Gronemeyer H., and Rochette-Egly C. TIF2 mediates the synergy between RARalpha 1 activation functions AF-1 and AF-2. J Biol Chem 277 (2002) 37961-37966
27. Warnmark A., Treuter E., Wright A.P., and Gustafsson J.A. Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation. Mol Endocrinol 17 (2003) 1901-1909
28. Glass C.K., Rose D.W., and Rosenfeld M.G. Nuclear receptor coactivators. Current Opin Cell Biol 9 (1997) 222-232
29. Horwitz K.B., Jackson T.A., Bain D.L., Richer J.K., Takimoto G.S., and Tung L. Nuclear receptor coactivators and corepressors. Mol Endocrinol 10 (1996) 1167-1177
30. Loven M.A., Muster N., Yates J.R., and Nardulli A.M. A novel estrogen receptor alpha-associated protein, template-activating factor I beta, inhibits acetylation and transactivation. Mol Endocrinol 17 (2003) 67-78
31. McKenna N.J., Lanz R.B., and O'Malley B.W. Nuclear receptor coregulators: cellular and molecular biology. Endocrine Rev 20 (1999) 321-344
32. Yamamoto K.R., Darimont B.D., Wagner R.L., and Iniguez-Lluhi J.A. Building transcriptional regulatory complexes: signals and surfaces. Cold Spring Harb Symp Quant Biol 63 (1998) 587-598
33. Hittelman A.B., Burakov D., Iniguez-Lluhi J.A., Freedman L.P., and Garabedian M.J. Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins. EMBO J 18 (1999) 5380-5388
34. Darimont B.D., Wagner R.L., Apriletti J.W., Stallcup M.R., Kushner P.J., Baxter J.D., et al. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev 12 (1998) 3343-3356
35. Brzozowski A.M., Pike A.C., Dauter Z., Hubbard R.E., Bonn T., Engstrom O., et al. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389 (1997) 753-758
36. Fagart J., Wurtz J.M., Souque A., Hellal-Levy C., Moras D., and Rafestin-Oblin M.E. Antagonism in the human mineralocorticoid receptor. EMBO J 17 (1998) 3317-3325
37. Tanenbaum D.M., Wang Y., Williams S.P., and Sigler P.B. Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc Natl Acad Sci U S A 95 (1998) 5998-6003
38. Williams S.P., and Sigler P.B. Atomic structure of progesterone complexed with its receptor. Nature 393 (1998) 392-396
39. Matias P.M., Donner P., Coelho R., Thomaz M., Peixoto C., Macedo S., et al. Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations. J Biol Chem 275 (2000) 26164-26171
40. Kauppi B., Jakob C., Farnegardh M., Yang J., Ahola H., Alarcon M., et al. The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonism. J Biol Chem 278 (2003) 22748-22754
41. Pike A.C., Brzozowski A.M., Hubbard R.E., Bonn T., Thorsell A.G., Engstrom O., et al. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J 18 (1999) 4608-4618
42. Hard T., Kellenbach E., Boelens R., Maler B.A., Dahlman K., Freedman L.P., et al. Solution structure of the glucocorticoid receptor DNA-binding domain. Science 249 (1990) 157-160
43. Schwabe J.W., Neuhaus D., and Rhodes D. Solution structure of the DNA-binding domain of the oestrogen receptor. Nature 348 (1990) 458-461
44. Schwabe J.W., Chapman L., Finch J.T., and Rhodes D. The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell 75 (1993) 567-578
45. Shaffer P.L., Jivan A., Dollins D.E., Claessens F., and Gewirth D.T. Structural basis of androgen receptor binding to selective androgen response elements. Proc Natl Acad Sci U S A 101 (2004) 4758-4763
46. Claessens F., and Gewirth D.T. DNA recognition by nuclear receptors. Essays Biochem 40 (2004) 59-72
47. Chandra V., Huang P., Hamuro Y., Raghuram S., Wang Y., Burris T.P., et al. Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA. Nature 456 (2008) 350-356
48. Baskakov I.V., Kumar R., Srinivasan G., Ji Y.S., Bolen D.W., and Thompson E.B. Trimethylamine N-oxide-induced cooperative folding of an intrinsically unfolded transcription-activating fragment of human glucocorticoid receptor. J Biol Chem 274 (1999) 10693-10696
49. Kumar R., Baskakov I.V., Srinivasan G., Bolen D.W., Lee J.C., and Thompson E.B. Interdomain signaling in a two-domain fragment of the human glucocorticoid receptor. J Biol Chem 274 (1999) 24737-24741
50. Kumar R., Lee J.C., Bolen D.W., and Thompson E.B. The conformation of the glucocorticoid receptor af1/tau1 domain induced by osmolyte binds co-regulatory proteins. J Biol Chem 276 (2001) 18146-18152
51. Kumar R., Serrette J.M., Khan S.H., Miller A.L., and Thompson E.B. Effects of different osmolytes on the induced folding of the N-terminal activation domain (AF1) of the glucocorticoid receptor. Arch Biochem Biophys 465 (2007) 452-460
52. Warnmark A., Wikstrom A., Wright A.P., Gustafsson J.A., and Hard T. The N-terminal regions of estrogen receptor alpha and beta are unstructured in vitro and show different TBP binding properties. J Biol Chem 276 (2001) 45939-45944
53. Wardell S.E., Kwok S.C., Sherman L., Hodges R.S., and Edwards D.P. Regulation of the amino-terminal transcription activation domain of progesterone receptor by a cofactor-induced protein folding mechanism. Mol Cell Biol 25 (2005) 8792-8808
54. Bain D.L., Franden M.A., McManaman J.L., Takimoto G.S., and Horwitz K.B. The N-terminal region of the human progesterone A-receptor. Structural analysis and the influence of the DNA binding domain. J Biol Chem 275 (2000) 7313-7320
55. Lavery D.N., and McEwan I.J. Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations. Biochem J 391 (2005) 449-464
56. Dahlman-Wright K., Baumann H., McEwan I.J., Almlof T., Wright A.P.H., Gustafsson J.A., et al. Structural characterization of a minimal functional transactivation domain from the human glucocorticoid receptor. Proc Natl Acad Sci U S A 92 (1995) 1699-1703
57. Almlof T., Wallberg A.E., Gustafsson J.A., and Wright A.P.H. Role of important hydrophobic amino acids in the interaction between the glucocorticoid receptor tau1-core activation domain and target factors. Biochem 37 (1998) 9586-9594
58. Reid J., Kelly S.M., Watt K., Price N.C., and McEwan I.J. Conformational analysis of the androgen receptor amino-terminal domain involved in transactivation. J Biol Chem 277 (2002) 20079-20086
59. Uversky V.N., Oldfield C.J., and Dunker A.K. Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling. J Mol Recognit 18 (2005) 343-384
60. Fink A.L. Natively unfolded proteins. Curr Opin Struct Biol 15 (2005) 35-41
61. Dunker A.K., Cortese M.S., Romero P., Iakoucheva L.M., and Uversky V.N. Flexible nets. The roles of intrinsic disorder in protein interaction networks. FEBS J 272 (2005) 5129-5148
62. Tompa P. The interplay between structure and function in intrinsically unstructured proteins. FEBS Lett 579 (2005) 3346-3354
63. Liu J., Perumal N.B., Oldfield C.J., Su E.W., Uversky V.N., and Dunker A.K. Intrinsic disorder in transcription factors. Biochem 45 (2006) 6873-6888
64. Hegyi H., Schad E., and Tompa P. Structural disorder promotes assembly of protein complexes. BMC Struct Biol 7 (2007) 65
65. Minezaki Y., Homma K., Kinjo A.R., and Nishikawa K. Human transcription factors contain a high fraction of intrinsically disordered regions essential for transcriptional regulation. J Mol Biol 359 (2006) 1137-1149
66. Garza A.S., Ahmad N., and Kumar R. Role of intrinsically disordered protein regions/domains in transcriptional regulation. Life Sci 84 (2009) 189-193
67. Dunker A., and Uversky V. Signal transduction via unstructured protein conduits. Nat Chem Biol 4 (2008) 229-230
68. Dyson H., and Wright P. Coupling of folding and binding for unstructured proteins. Curr Opin Struct Biol 12 (2002) 54-60
69. Hoffman R., and Sykes B. Isoform-specific variation in the intrinsic disorder of troponin I. Proteins 73 (2008) 338-350
70. Minezaki Y., Homma K., Kinjo A., and Nishikawa K. Human transcription factors contain a high fraction of intrinsically disordered regions essential for transcriptional regulation. J Mol Biol 359 (2006) 1137-1149
71. Kumar R., Volk D., Li J., Lee J., Gorenstein D., and Thompson E. TATA box binding protein induces structure in the recombinant glucocorticoid receptor AF1 domain. Proc Natl Acad Sci U S A 101 (2004) 16425-16430
72. Mark W., Liao J., Lu Y., Ayed A., Laister R., Szymczyna B., et al. Characterization of segments from the central region of BRCA1: an intrinsically disordered scaffold for multiple protein-protein and protein-DNA interactions?. J Mol Biol 345 (2005) 275-287
73. Kumar R., Betney R., Li J., Thompson E., and McEwan I. Induced alpha-helix structure in AF1 of the androgen receptor upon binding transcription factor TFIIF. Biochem 43 (2004) 3008-3013
74. Shen F., Triezenberg S., Hensley P., Porter D., and Knutson J. Transcriptional activation domain of the herpesvirus protein VP16 becomes conformationally constrained upon interaction with basal transcription factors. J Biol Chem 271 (1996) 4827-4837
75. Shoemaker B., Portman J., and Wolynes P. Speeding molecular recognition by using the folding funnel: the fly-casting mechanism. Proc Natl Acad Sci U S A 97 (2000) 8868-8873
76. Singh G., and Dash D. Intrinsic disorder in yeast transcriptional regulatory network. Proteins 68 (2007) 602-605
77. Shoemaker B.A., Portman J.J., and Wolynes P.J. Speeding molecular recognition by using the folding funnel: The fly-casting mechanism. Proc Natl Acad Sci U S A 97 (2000) 8868-8873
78. McEwan I., Dahlman-Wright K., Ford J., and Wright A. Functional interaction of the c-Myc transactivation domain with the TATA binding protein: evidence for an induced fit model of transactivation domain folding. Biochemistry 35 (1996) 9584-9593
79. Bienkiewicz E., Adkins J., and Lumb K. Functional consequences of preorganized helical structure in the intrinsically disordered cell-cycle inhibitor p27(Kip1). Biochemistry 41 (2002) 752-759
80. Dunker A., Brown C., Lawson J., Iakoucheva L., and Obradović Z. Intrinsic disorder and protein function. Biochemistry 41 (2002) 6573-6582
81. Uversky V. Natively unfolded proteins: a point where biology waits for physics. Protein Sci 11 (2002) 739-756
82. Dyson H., and Wright P. Intrinsically unstructured proteins and their functions. Nat Rev Mol Cell Biol 6 (2005) 197-208
83. Sartorius C.A., Melville M.Y., Hovland A.R., Tung L., Takimoto G.S., and Horwitz K.B. A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform. Mol Endocrinol 8 (1994) 1347-1360
84. Copik A.J., Webb M.S., Miller A.L., Wang Y., Kumar R., and Thompson E.B. Activation function 1 of glucocorticoid receptor binds TATA-binding protein in vitro and in vivo. Mol Endocrinol 20 (2006) 1218-1230
85. Keeton E.K., Fletcher T.M., Baumann C.T., Hager G.L., and Smith C.L. Glucocorticoid receptor domain requirements for chromatin remodeling and transcriptional activation of the mouse mammary tumor virus promoter in different nucleoprotein contexts. J Biol Chem 277 (2002) 28247-28257
86. Stenoien D.L., Patel K., Mancini M.G., Dutertre M., Smith C.L., O'Malley B.W., et al. FRAP reveals that mobility of oestrogen receptor-alpha is ligand- and proteasome-dependent. Nat Cell Biol 3 (2001) 15-23
87. Lazennec G., Ediger T.R., Petz L.N., Nardulli A.M., and Katzenellenbogen B.S. Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes. Mol Endocrinol 11 (1997) 1375-1386
88. McEwan I.J., Lavery D., Fischer K., and Watt K. Natural disordered sequences in the amino terminal domain of nuclear receptors: lessons from the androgen and glucocorticoid receptors. Nucl Recept Signal 5 (2007) e001
89. Combet C., Blanchet C., Geourjon C., and Deléage G. NPS@: Network protein sequence analysis. TIBS 25 3 [291] (2000) 147-150